Milan, June 5, 2019 – Recently, a controlled clinical study was presented on Blefastop, an ocular and periocular innovative therapeutic solution as adjuvant in blepharitis.
Milan, Italy, May 22, 2019 – NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and Santen Pharmaceutical Co. Ltd, a global leader in ophthalmology, announce today the extension of their original agreement for Europe signed in December 2017.
Milan, February 26th 2019 – NTC Srl, an Italian pharmaceutical company with significant expertise in research and development in ophthalmology, announces today a commercial partnership with Bruno Farmaceutici S.p.A.
During FacoElche Congress (31st January – 2nd February 2019), NTC Ophthalmics Ibérica organized its first Symposium focused on the rational use of topical antibiotics in ophthalmology.